JP2012236772A - スピカマイシン誘導体を有するリポソーム製剤 - Google Patents

スピカマイシン誘導体を有するリポソーム製剤 Download PDF

Info

Publication number
JP2012236772A
JP2012236772A JP2009223004A JP2009223004A JP2012236772A JP 2012236772 A JP2012236772 A JP 2012236772A JP 2009223004 A JP2009223004 A JP 2009223004A JP 2009223004 A JP2009223004 A JP 2009223004A JP 2012236772 A JP2012236772 A JP 2012236772A
Authority
JP
Japan
Prior art keywords
liposome
krn5500
phospholipid
membrane
liposome preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009223004A
Other languages
English (en)
Japanese (ja)
Inventor
Keiko Yamashita
恵子 山下
Shigenori Nozawa
滋典 野沢
Atsushi Miwa
篤史 三輪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Kyowa Kirin Co Ltd
Original Assignee
Terumo Corp
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp, Kyowa Hakko Kirin Co Ltd filed Critical Terumo Corp
Priority to JP2009223004A priority Critical patent/JP2012236772A/ja
Priority to PCT/JP2010/066808 priority patent/WO2011037252A1/fr
Publication of JP2012236772A publication Critical patent/JP2012236772A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009223004A 2009-09-28 2009-09-28 スピカマイシン誘導体を有するリポソーム製剤 Withdrawn JP2012236772A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009223004A JP2012236772A (ja) 2009-09-28 2009-09-28 スピカマイシン誘導体を有するリポソーム製剤
PCT/JP2010/066808 WO2011037252A1 (fr) 2009-09-28 2010-09-28 Préparation liposomale contenant un dérivé de spicamycine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009223004A JP2012236772A (ja) 2009-09-28 2009-09-28 スピカマイシン誘導体を有するリポソーム製剤

Publications (1)

Publication Number Publication Date
JP2012236772A true JP2012236772A (ja) 2012-12-06

Family

ID=43795990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009223004A Withdrawn JP2012236772A (ja) 2009-09-28 2009-09-28 スピカマイシン誘導体を有するリポソーム製剤

Country Status (2)

Country Link
JP (1) JP2012236772A (fr)
WO (1) WO2011037252A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061562A1 (fr) * 2015-10-07 2017-04-13 塩水港精糖株式会社 Liposome comprenant un composé de taxane

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150157610A1 (en) * 2012-05-23 2015-06-11 Osaka University Pharmaceutical composition for treating inflammatory disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE475411T1 (de) * 2001-10-03 2010-08-15 Celator Pharmaceuticals Inc Liposomenladung mit metallionen
WO2004087094A2 (fr) * 2003-04-02 2004-10-14 Celator Pharmaceuticals, Inc. Compositions pour traiter la resistance aux medicaments
JP4712341B2 (ja) * 2003-10-20 2011-06-29 日油株式会社 リン脂質膜製剤
DE102006015271A1 (de) * 2006-04-01 2007-10-11 Lohmann & Rauscher Gmbh & Co. Kg Biguanidhaltige Liposomen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017061562A1 (fr) * 2015-10-07 2017-04-13 塩水港精糖株式会社 Liposome comprenant un composé de taxane
JPWO2017061562A1 (ja) * 2015-10-07 2018-07-05 塩水港精糖株式会社 タキサン化合物を内包するリポソーム

Also Published As

Publication number Publication date
WO2011037252A1 (fr) 2011-03-31

Similar Documents

Publication Publication Date Title
JP4885715B2 (ja) イリノテカン製剤
JP5770336B2 (ja) リポソーム組成物の製造方法
US8241663B2 (en) Liposome preparation
TW202011941A (zh) 用於治療肺部疾病的可吸入的緩釋組成物
JP6263609B2 (ja) リポソーム組成物及びその製造方法
US20240082154A1 (en) Disease-site-specific liposomal formulation
JP4874097B2 (ja) 水難溶性カンプトテシン含有リポソーム製剤
TW202312985A (zh) 靶向動脈粥樣硬化脂質體奈米載體遞送系統及其製備方法
JP4791067B2 (ja) リポソーム製剤の製造方法
JPWO2020071349A1 (ja) 薬物を内包するリポソーム組成物およびプラチナ製剤を含む組合せ医薬
WO2011037252A1 (fr) Préparation liposomale contenant un dérivé de spicamycine
JPWO2005021012A1 (ja) ゲムシタビン封入薬剤担体
JP2014506918A (ja) 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物
EP3395370B1 (fr) Liposomes et composition de liposomes
JP7186385B2 (ja) 疾患部位特異的リポソーム製剤
WO2014050509A1 (fr) Liposome et préparation de liposome

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20121204